MedPath

Detection of EGFR and K-ras gene mutations in serum of non-small cell lung cancer patients

Phase 2
Conditions
Adenocarcinoma of the lung
Registration Number
JPRN-UMIN000006762
Lead Sponsor
Osaka Medical Center for Cancer and Cardiovascular Diseases
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
288
Inclusion Criteria

Not provided

Exclusion Criteria

Nothing

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of evaluation of EGFR and K-ras gene mutation with plasma
Secondary Outcome Measures
NameTimeMethod
Correlation between EGFR and K-ras gene mutation evaluated with plasma
© Copyright 2025. All Rights Reserved by MedPath